Replies to post #333782 on Avid Bioservices Inc (CDMO)

[jakedogman1]

Fourth qtr ending April 30 is prob a dud given machine issue... is that already baked into the SP... the question is what will FY 21 look like...

Darzalex approval EU and US... Roche approval in Oct... what else is brewing?

Overall demand in CDMO space is strong w/ Covid issues...